MicroPort CardioFlow Medtech Corporation is a medical device company specializing in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases. Its product portfolio includes transcatheter aortic valves, left atrial appendage closure systems, and cardiac rhythm management devices like pacemakers and implantable cardioverter-defibrillators. The company was founded in 2015 and is headquartered in Shanghai, China.
We are taking a close look at the Microport Cardioflowās valuation. We are of the view that the companyās fair value should be around USD 3.0 billion.